camptothecin has been researched along with Superior Vena Cava Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, S; Hayashi, T; Hirose, S; Hoshino, M; Machino, C; Ogura, N; Oikawa, H; Sakai, G; Satou, T | 1 |
| Bonetti, A; Giuliani, J; Martelli, S; Piacentini, P | 1 |
2 other study(ies) available for camptothecin and Superior Vena Cava Obstruction
| Article | Year |
|---|---|
[A Case of Superior Vena Cava Syndrome Due to Recurrent Breast Cancer Effectively Treated by Trastuzumab Deruxtecan].
Topics: Breast Neoplasms; Camptothecin; Female; Humans; Immunoconjugates; Middle Aged; Neoplasm Recurrence, Local; Superior Vena Cava Syndrome; Trastuzumab | 2022 |
Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis".
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Collateral Circulation; Colorectal Neoplasms; Disease Progression; Enoxaparin; Fatal Outcome; Female; Fibrinolytic Agents; Fluorouracil; Humans; Leucovorin; Middle Aged; Superior Vena Cava Syndrome; Tomography, X-Ray Computed; Venous Thromboembolism | 2015 |